Credit: CC0 Public Domain Scientists reported setbacks Tuesday in the quest for an AIDS cure, and highlighted concerns about inconclusive evidence linking a promising new HIV drug to birth defects. According to research presented at the 22nd International AIDS Conference in Amsterdam, four cases of “neural tube” defects were recorded among the pregnancies of 426 […]Continue Reading ...
People waiting to be attended at Maputo Hospital in Southern Mozambique. Credit: Author: Andalu Vilasanjuan HIV diagnosis is the first of many steps in the path to global disease control. However, in Southern Mozambique, more than half of people diagnosed with HIV do not initiate the next steps in the cascade of HIV care, and […]Continue Reading ...
Credit: CC0 Public Domain The International Antiviral Society-USA Panel has released updated recommendations for the treatment and prevention of HIV infection in adults, published in the Journal of the American Medical Association. Michael Saag, M.D., director of the University of Alabama at Birmingham’s Center for AIDS Research, served as the article’s lead author. The recommendations, […]Continue Reading ...
HIV infecting a human cell. Credit: NIH Researchers have reported the results of the first randomised clinical trial to test a novel strategy involving waking up and then killing the ‘sleeping’ HIV that is hiding in the body using an experimental approach known as ‘kick and kill’. Led by Imperial College London, the University of […]Continue Reading ...
Inositol hexakisphosphate fits into the pore structures (pink) of the HIV capsid (teal), and makes the makes the capsid stronger, protecting the genetic material inside. Credit: UNSW Scientists from UNSW Sydney and the UK have discovered that the human immunodeficiency virus (HIV) hijacks a small molecule from the host cell to protect itself from being […]Continue Reading ...
European patents expired on July 25 for Truvada, allowing EU authorities to clear the way for cheaper generics to enter the market Patient associations on Thursday lauded an EU decision to allow the sale of generic versions of Truvada, an anti-retroviral medicine used by those diagnosed HIV-positive, the virus causing AIDS. “This decision is historic […]Continue Reading ...
Carolina del Real, 37, was diagnosed as HIV positive seven years ago, and now devotes her time to teaching people about prevention The winds of change are blowing through Chile where a youthful sexual revolution is shattering taboos—but also sparking an explosion of HIV cases that has set off alarm bells in the traditionally conservative […]Continue Reading ...
Credit: pixabay By destroying the regulatory genes of the AIDS virus HIV-1 using the genome editing system CRISPR/Cas9, a Japanese research group has succeeded in blocking the production of HIV-1 by infected cells. Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by […]Continue Reading ...
Credit: CC0 Public Domain Among the more than 1 million people in the U.S. living with HIV, 19 percent meet the criteria for an alcohol use disorder. The consequences can be severe, with heavy drinking associated with increased liver disease, greater engagement in risky sexual behavior, lower adherence to antiretroviral therapy and greater risk of […]Continue Reading ...
Thousands of experts and activists descend on Amsterdam Monday to bolster the battle against AIDS amid warnings that “dangerous complacency” may cause a resurgence of the epidemic that has already killed 35 million people. Rather than closing in on the goal of “ending” AIDS, new HIV infections have surged in parts of the world as […]Continue Reading ...
Credit: The City University of New York HIV testing is a first step and key to stemming the rate of HIV infections around the world. In sub-Saharan African countries, HIV testing rates continue to be suboptimal, creating an urgent need to explore strategic and cost-effective approaches to increase the uptake of HIV testing, particularly among […]Continue Reading ...
Credit: CC0 Public Domain Public health officials are expanding efforts to get the HIV prevention pill into the hands of those at risk, in a nationwide effort to curb infections. But the officials are hitting roadblocks—the drug’s price tag, which has surged in recent years, and changes in insurance coverage that put a heftier financial […]Continue Reading ...
Simplified schematic of HIV transmission. After exposure to HIV through unprotected sexual contact, HIV has to pass several physiological barriers in the exposed individual (e.g. mucosal barrier) to reach a cellular compartment, where it can replicate in sufficient numbers to establish a systemic infection. However, not every exposure leads to infection. HIV prophylaxis with anti-HIV […]Continue Reading ...
HIV infecting a human cell. Credit: NIH Multiple barriers may stop high-risk individuals from accessing an HIV drug that can reduce the subsequent risk of infection, according to a new University of Michigan study. Researchers outlined solutions that would help overcome barriers that make it harder for underserved populations to access pre-exposure prophylaxis (PrEP). The […]Continue Reading ...
Brains are composed of different cell types and the image from microscopy shows what cells EcoHIV infects in a mixture of mouse brain cells in tissue culture. The colors label specific elements in the cell mixture: blue shows DNA found in all cells, red shows a specific protein CD11b that is found in microglia, the […]Continue Reading ...
- Medicine on the front line to be presented at Medical Innovation 2018
- Harbour Biomed and Kelun-Biotech collaborate to develop, commercialize anti-PD-L1 antibody
- The man who sold America on vitamin D — and profited in the process
- Finding the light in antimicrobials
- Unique pain program helps surgical patients wean off opioids safely and effectively
- Strawberries could mitigate colonic inflammation
- FDA Accepts New Drug Application (NDA) to Review Midazolam Nasal Spray, an Investigational Product for the Acute Treatment of Seizure Clusters
- Using Facebook to help young adults quit smoking
- ‘Liquid biopsy’ predicts lymphoma therapy success within days | News Center
- 5 Questions with Jordan Orange, Chair of Pediatrics
- New assay may help improve both sarcoma diagnosis and treatment
- New class of insect repellents to fight against mosquito-borne diseases
- ACA Coverage Gains Include Workers Without Insurance
- 3-D printed biomaterials for bone tissue engineering
- Prenatal exposure to acute stress can affect cognitive function in children of low-income households
- New study examines scope of state policies targeting drug use by pregnant women
- Researchers find long-term structural, functional brain abnormalities in individuals with AUDs
- Shortage of insurance fraud cops sparks campaign debate
- Researchers find STAT3 as therapeutic target for chronic active EBV infection
- Health Tip: Keep Diabetic Feet Healthier